Hermed Medrott Medical
0630.874.538 · rovalta.com · 26/09/2026
NORMAL SITUATION
Hermed Medrott Medical
Company — Normal situation.
Strike-off: 11 août 2026
Financial year 2026 · Closed on 30/06/2026
Net result-5 k €+65,4 %over 1 year
Gross margin-4,9 k €+49,2 %over 1 year
Equity-125,4 k €-4,2 %over 1 year
Overview
Identity
Source · BCE/KBOHermed Medrott Medical is a Private company with limited liability incorporated in 2015.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0630.874.538
- Incorporation
- 27/05/2015
- Legal form
- Private company with limited liability
- Contributed capital
- 6 200,00 €
- Latest accounts
- 30/06/2026
Financials
Source · NBB, 11 filingsTrend over 8 financial years
| 2026 | 2025 | 2024 | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -4,9 k € | +49.2% | -9,6 k € | +7.2% | -10,4 k € | +4.8% | -10,9 k € | -212% | 9,7 k € |
| EBITDA | -4,9 k € | +52.7% | -10,3 k € | +5.2% | -10,9 k € | +7.3% | -11,8 k € | -233% | 8,9 k € |
| Operating result | -4,9 k € | +52.7% | -10,3 k € | +5.2% | -10,9 k € | +7.3% | -11,8 k € | -233% | 8,9 k € |
| Net result | -5 k € | +65.4% | -14,4 k € | +17.2% | -17,5 k € | +0.2% | -17,5 k € | -441% | 5,1 k € |
| Balance sheet | |||||||||
| Equity | -125,4 k € | -4.2% | -120,4 k € | -13.6% | -105,9 k € | -19.7% | -88,5 k € | -24.6% | -71 k € |
| Total assets | 1,6 k € | -84.2% | 10,3 k € | -65.1% | 29,7 k € | -49.0% | 58,2 k € | -50.2% | 116,9 k € |
| Cash | 568,1 € | -85.6% | 3,9 k € | -85.7% | 27,6 k € | -40.1% | 46 k € | -55.8% | 104,2 k € |
| Debts | 127 k € | -2.8% | 130,7 k € | -3.6% | 135,6 k € | -7.6% | 146,7 k € | -20.5% | 184,4 k € |
Board of directors
Source · NBB, accounts to 30/06/20262 active · 5 ended
Active mandates
Mirco Michael Möller
ActiveJacobus Marinus Van Diest
ActiveEnded mandates
Mirco Michael Möller
EndedMirco Michael Möller Möller
EndedMirco, Michael Möller
EndedJacobus Marinus Van Diest
EndedFinancials
Full financial information
Source · NBB| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2026 | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 |
| Closing of the financial year | 30/06/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 6 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 16/07/2026 | 16/07/2026 | 24/10/2025 | 31/07/2024 | 16/05/2023 | 21/06/2022 |
| General meeting | 30/06/2026 | 30/06/2026 | 25/08/2025 | 30/07/2024 | 12/05/2023 | 13/05/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 11 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 30/06/2026 | 30/06/2026 | 16/07/2026 | Dutch | |
| Abridged model | 31/12/2025 | 30/06/2026 | 16/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 25/08/2025 | 24/10/2025 | Dutch | |
| Abridged model | 31/12/2023 | 30/07/2024 | 31/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 12/05/2023 | 16/05/2023 | Dutch | |
| Abridged model | 31/12/2021 | 13/05/2022 | 21/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 14/05/2021 | 17/05/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 18/08/2020 | Dutch | |
| Abridged model | 31/12/2018 | 27/05/2019 | 18/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 25/05/2018 | 06/06/2018 | Dutch | |
| Abridged model | 31/12/2016 | 12/05/2017 | 20/06/2017 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20262 active · 5 ended
Active mandates
Mirco Michael Möller
ActiveJacobus Marinus Van Diest
ActiveEnded mandates
Mirco Michael Möller
EndedMirco Michael Möller Möller
EndedMirco, Michael Möller
EndedJacobus Marinus Van Diest
EndedOwnership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other21/08/2026GEWONE ALGEMENE VERGADERING VOOR HET BOEKJAAR
- Mandates15/07/2026Herbenoeming commissaris
- Mandates24/05/2023ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
- Mandates27/10/2020ONTSLAGEN - BENOEMINGEN
- Mandates23/07/2019ONTSLAGEN - BENOEMINGEN
- Mandates21/04/2017ONTSLAGEN - BENOEMINGEN
- Other14/12/2016STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Registered office04/07/2016MAATSCHAPPELIJKE ZETEL
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 2026-5 k €↑
- 2025Annual accounts 2025-14,4 k €↑
- 2024Annual accounts 2024-17,5 k €↑
- 2023Annual accounts 2023-17,5 k €↓
- 2022Annual accounts 20225,1 k €↓
- 2021Annual accounts 20217,5 k €↑
- 2018Annual accounts 2018-35,1 k €↓
- 2017Annual accounts 2017-22,6 k €
- 27/05/2015IncorporationPrivate company with limited liability